Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) was the target of a significant drop in short interest in December. As of December 29th, there was short interest totalling 912,469 shares, a drop of 6.3% from the December 15th total of 974,176 shares. Based on an average daily volume of 229,047 shares, the short-interest ratio is currently 4.0 days. Approximately 7.0% of the shares of the stock are sold short.
Separately, Maxim Group restated a “buy” rating and set a $1.50 price target on shares of Xtant Medical in a research report on Wednesday, November 22nd.
Shares of Xtant Medical (XTNT) opened at $0.57 on Thursday. Xtant Medical has a 12-month low of $0.29 and a 12-month high of $1.21. The firm has a market capitalization of $10.46, a PE ratio of -0.35 and a beta of 0.63.
Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.